MIRA Pharmaceuticals Inc —— 现金流量表 (NASDAQ:MIRA) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -4.53 M-5.56 M-4.66 M -4.66 M 投资活动产生的现金 ——— — 融资活动产生的现金 8.78 M3.79 M8.18 M 8.18 M 自由现金流 -4.53 M-5.56 M-4.66 M -4.66 M

新闻

MIRA完成口服NMDA药物Ketamir-2一期临床试验

MIRA completes Phase 1 trial of oral NMDA drug Ketamir-2

MIRA制药公司开始Ketamir-2临床试验的最终剂量测试

MIRA Pharmaceuticals initiates final dosing in phase 1 trial of Ketamir-2

美瑞制药批准CEO激励奖励，包括SKNY收购奖金

Mira Pharmaceuticals approves CEO incentive awards including SKNY acquisition bonus

美瑞制药将场内发行额增加1524.16万美元

Mira Pharmaceuticals increases at-the-market offering by $15.2 million

MIRA启动Ketamir-2神经病理性疼痛药物的I期多递增剂量研究

MIRA begins phase 1 MAD study of Ketamir-2 for neuropathic pain

MIRA Pharmaceuticals Stock Surges Following Positive Preclinical Data - Mira Pharmaceuticals (NASDAQ:MIRA)

Mira制药公司疼痛治疗研究结果积极，股价飙升